Extramammary Paget Disease


Article Author:
Brianna McDaniel
Falon Brown


Article Editor:
Jonathan Crane


Editors In Chief:
Stephen Leslie
Karim Hamawy


Managing Editors:
Avais Raja
Orawan Chaigasame
Carrie Smith
Abdul Waheed
Khalid Alsayouri
Kyle Blair
Trevor Nezwek
Radia Jamil
Erin Hughes
Patrick Le
Anoosh Zafar Gondal
Saad Nazir
William Gossman
Hassam Zulfiqar
Navid Mahabadi
Hussain Sajjad
Steve Bhimji
Muhammad Hashmi
John Shell
Matthew Varacallo
Heba Mahdy
Ahmad Malik
Abbey Smiley
Sarosh Vaqar
Mark Pellegrini
James Hughes
Beata Beatty
Daniyal Ameen
Altif Muneeb
Beenish Sohail
Nazia Sadiq
Hajira Basit
Phillip Hynes
Komal Shaheen
Sandeep Sekhon


Updated:
9/23/2019 11:36:49 AM

Introduction

Extramammary Paget disease (EMPD) is a rare dermatologic condition that frequently presents in areas where apocrine sweat glands are abundant, most commonly the vulva, although perineal, scrotal, perianal, and penile skin may also be affected. Lesions clinically present as erythematous, well-demarcated plaques that may become erosive, ulcerated, scaly, or eczematous. Extramammary Paget disease has a female predominance and usually occurs in the sixth to eighth decades of life. Professionals disagree about many aspects of EMPD, for example, the prevalence of concurrent vulvar adenocarcinoma or invasive EMPD, association with regional and distant cancers, and recurrence rates following surgical excision. Early recognition is imperative because the diagnosis is frequently delayed and there is a high incidence of associated invasive disease.[1][2][3][4][5]

Etiology

The etiology of primary EMPD has been debated but appears to be of apocrine origin. Secondary extramammary Paget disease represents an extension of an underlying adnexal adenocarcinoma or an underlying visceral malignancy, most commonly urothelial or anorectal, but it may also be cervical, prostatic, ovarian, or endometrial.

Epidemiology

EMPD is an uncommon condition with only a few hundred cases reported in the world medical literature. Precise incidence is unknown. EMPD represents 6.5% of all cutaneous Paget disease and mainly affects patients between 50 to 80 years of age, with a peak age of 65.3 years old. Caucasians and women are more commonly affected, although a male predominance exists in Asia. The vulva is the most frequently involved site, with 65% of EMPD located in this region. EMPD has also been reported in areas with modified apocrine glands, such as the external auditory canal in association with ceruminous carcinoma, and possibly in the eyelid accompanying carcinoma of Moll's glands. Rare sites of involvement include the buttock, glans penis, knee, thigh, abdomen, umbilicus, lower anterior chest, and scalp.

There is an important association between EMPD and another underlying malignancy in at least 10% to 30% of cases, so a thorough investigation to rule out malignancy is critical.

Pathophysiology

The precise pathogenesis of EMPD is still the subject of controversy. The literature seems to indicate that extramammary Paget disease does not have a uniform histogenesis. Approximately 25% of cases have a primary cutaneous adnexal carcinoma, mostly of apocrine type, but sometimes derived from periurethral, eccrine, perianal, or Bartholin's glands. An additional 10% to 15% of EMPD patients have an internal carcinoma involving the bladder, rectum, cervix, prostate, or urethra, which appears to be of etiological significance. Recently theories have postulated that EMPD is associated with Toker cells, which are present in both mammary and vulvar tissue.

Due to the histologic extension beyond the clinically abnormal area, local recurrence of extramammary Paget disease is relatively common. The prognosis is favorable, except in cases with an underlying visceral or adnexal carcinoma, in which the mortality rate is greater than 50%. Decreased survival is also associated with increased serum CEA levels, tumor invasion level, the presence of nodules in the primary lesion, and lymph node metastases. Spontaneous regression has been described in the literature after partial surgical excision. Metastatic extramammary Paget disease is rather rare, but it may spread to regional lymph nodes and visceral organs.[6][7][8]

Histopathology

In EMPD, the proliferative neoplastic cell is the Paget cell (PC). These cells have ample pale cytoplasm and large pleomorphic nuclei, sometimes with a prominent nucleolus. Mitoses are commonly present. Occasional cells have an eccentric nucleus and the appearance of a signet ring.

In early lesions, the cells are arranged singly or in small groups, sometimes with the glandular formation in the basal layer of the epidermis. The entire thickness of the epidermis can be involved, although the greatest concentration of tumor cells is in the lower part of the epidermis. The pagetoid cells usually spread into the contiguous epithelium of eccrine ducts and hair follicles. Uncommonly, Paget cells may invade the dermis.

Unlike the majority of cases of mammary Paget disease, the Paget cells in extramammary Paget disease contain ample mucin, which may be confirmed by staining with Alcian blue, mucicarmine, Periodic acid–Schiff (PAS), and colloidal iron. Immunohistochemistry is often used to diagnose Paget disease and to identify the likely cell of origin. Paget cells usually stain for markers of eccrine and apocrine derivation including low molecular weight cytokeratins (CK), periodic acid-Schiff (PAS), gross cystic disease fluid protein (GCDFP-15), and carcinoembryonic antigen (CEA). S100 staining is negative.

Extramammary Paget disease and mammary Paget disease and show characteristic, although slightly different immunophenotypes. Primary intra-epidermal Paget disease is GCDFP-15 positive, CK7 positive, and CK20 negative. Paget disease that has spread from an underlying internal carcinoma (EMPD) stains GCDFP-15 negative, CK7 negative, and CK20 positive. The main histological differential diagnoses to exclude in the vulva are superficial spreading malignant melanoma (PAS negative, S100 positive, cytokeratin negative, CEA negative) and anogenital intraepithelial neoplasia (S100 negative, PAS negative).

History and Physical

The primary lesions of EMPD are erythematous and scaly plaques, usually well delineated, and measure around several centimeters. One may observe crusting, weepy erosions or even ulcerations at a later stage. Scattered areas of erosion and white scale can give rise to a “strawberries and cream” appearance. The involved areas usually slowly expand, with a sharp demarcation between normal and involved skin. The lesions in EMPD can be nonspecific [commonly misdiagnosed as an inflammatory or infective skin condition (eczema, psoriasis, candidiasis)] and multiple topical therapies are often applied before the diagnosis is made. A median delay of 2 years in proper diagnosis has been reported. The most common presenting symptom in extramammary Paget disease is pruritus, but burning, tenderness, and edema may be experienced as well. Lesions occasionally show hypopigmentation or hyperpigmentation. Long-standing lesions may be modified by repeated trauma/excoriation or superimposed infection.

Hard nodules and regional lymph node enlargement may develop, resulting from the presence of an underlying carcinoma. ‘Underpants-pattern erythema’ is a specific clinical aspect of genital extramammary Paget disease starting in the groin and spreads peripherally to areas covered by underwear. This particular pattern is due to invasion of the lymphatic system by tumor and has an ominous prognosis, since it is associated with rapidly fatal distant metastases.

Evaluation

The diagnosis of EMPD must trigger a laboratory work-up aiming to detect an underlying malignancy. Depending on the area of skin lesions, the following examinations should be performed: cervicovaginal smear, rectocoloscopy, cystoscopy, abdominal ultrasound or computed tomography scanning, gastroduodenal fibroscopy, mammography, intravenous urography, the dosage of serum tumor markers (CEA, CA 19–9, CA 15–3).

A clinical follow-up needs to be long-term as some patients develop recurrences more than 15 years after initial treatment. For non-invasive EMPD, the follow-up could be biannual for 3 years, then annually for 10 years. For invasive EMPD or those associated with a distant tumor, the follow-up should be more frequent (3 or 4 times per year), with biopsy of any suspicious skin lesion. Specifically for perianal EMPD, follow up should involve an annual complete examination, punch biopsy of any new lesion, and proctosigmoidoscopy. These patients should undergo colonoscopy every 2 to 3 years. Vulvar EMPD may be followed up with regular vulvar inspection, punch biopsies to exclude invasive disease in any recurrent lesions, and hysteroscopy/regular pelvic ultrasound scans.

A lymph node staging system was proposed by Hatta and colleagues, where N0 implies no involvement of lymph nodes; N1, unilateral involvement; and N2 bilateral or distant-site disease. The Kaplan-Meier overall survival curve figured in this study depicts decreasing survival with increasing lymph node status. Thus, a clinical predicament arises when faced with managing a patient with histologically proven EMPD and negative clinical lymphadenopathy. This issue has been broached recently in the literature relating to 2 surgical aspects: the value of sentinel lymph node biopsy (SLNB) with or without complete lymph node dissection (CLND) and the pertinence of elective lymph node dissection (ELND) in managing invasive EMPD. The basis from which these procedures stem is centered on the notion that metastases first pass through the lymphatic system before disseminating systemically and that, by interrupting this passage, it may be possible to prevent widespread disease.

Treatment / Management

Surgery is still considered the gold standard of treatment for patients with EMPD. Over the years, many therapeutic modalities have been attempted on patients with EMPD to reduce the significant morbidity associated with the often-radical surgical treatments performed. Because of the rarity of this condition, experience in its management is limited. Due to the high frequency of recurrences after excision, adjunctive therapy is often used. The literature recommends a safety resection margin of 2 cm, although a 1 cm margin could be sufficient for lesions with clinically clear margins. A lower recurrence rate has been reported when utilizing Mohs micrographic surgery (MMS). A study by Coldiron and colleagues evaluated recurrence of EMPD after MMS versus conventional excision using fixed or frozen margins. They combined results from their own experience with those from a written survey of members of the American College of Micrographic Surgery and compared with cases selected from the literature that had undergone conventional surgery. Coldiron et al. reported a recurrence rate of 23% for MMS versus 33% for conventional excision with margin control.

Systemic chemotherapy (vincristine, docetaxel, carboplatin, 5-FU, mitomycin-C, etoposide) can be used if there are contraindications to surgery and radiotherapy.  Radiation treatment can be utilized for inoperable lesions or as adjuvant treatment to surgical excision, namely, in the case of postoperative recurrence; the results are better in primary in situ EMPD. Local application of cytotoxic drugs (bleomycin, 5-fluorouracil) alone is not sufficient, but may decrease the margins of the lesions or assist in visualization, rendering resection more efficacious. Intralesional interferon has given promising results in some patients. The topical immune-response modifier, imiquimod, has been successfully used in a small number of EMPD cases it appears to be helpful in superficial forms. Imiquimod can be considered an alternative to surgery, an adjunct before or after surgery, and even part of a therapeutic combination with other treatment modalities. Though only case reports or case series have been published thus far, results seem promising for Imiquimod.

Differential Diagnosis

Diagnosis and definitive treatment are often delayed due to the non-specific clinical findings resulting in misdiagnosis, and elderly patients frequently present late. EMPD is commonly mistaken for: contact dermatitis, fungal infection, psoriasis seborrheic dermatitis, anogenital intraepithelial neoplasia, lichen sclerosis, melanoma, mycosis fungoides, and histiocytosis. Perianal or vulvar EMPD may also be misdiagnosed as leukoplakia, squamous cell carcinoma, basal cell carcinoma, condylomata acuminate, hidradenitis suppurativa, or Crohn’s disease.

Enhancing Healthcare Team Outcomes

The diagnosis and management of extramammary Paget disease is with an interdisciplinary team that includes an oncologist, pathologist, dermatologist, primary care provider, nurse practitioner, and a surgeon. The condition is very rare and delay in diagnosis are very common. When an itchy or scaly rash is seen that persists, one should always have to to consider a malignant process, especially in older people. While the treatment for localized lesions is surgery, in many patients local spread has occurred by the time diagnosis is made. There is a high rate of recurrence after surgery and in these patients, systemic chemotherapy and/or radiation therapy is often utilized. The prognosis for most patients is guarded.[9]

Once treatment is completed, the should be monitored closely on follow up by their oncologist, nurse practitioner, and an oncology nurse. If there is any evidence of recurrence, the patient should be referred back to the specialist. It is important that the oncology nurse arrange regular followup appointments and educate the family on the need for close monitoring. If there is any concern regarding followup or lack of patient/family awareness, the nurse should involve the oncologist. Only with an interdisciplinary team will the best outcomes be achieved. [Level V]


  • Image 238 Not availableImage 238 Not available
    Contributed by DermNetNZ
Attributed To: Contributed by DermNetNZ

Interested in Participating?

We are looking for contributors to author, edit, and peer review our vast library of review articles and multiple choice questions. In as little as 2-3 hours you can make a significant contribution to your specialty. In return for a small amount of your time, you will receive free access to all content and you will be published as an author or editor in eBooks, apps, online CME/CE activities, and an online Learning Management System for students, teachers, and program directors that allows access to review materials in over 500 specialties.

Improve Content - Become an Author or Editor

This is an academic project designed to provide inexpensive peer-reviewed Apps, eBooks, and very soon an online CME/CE system to help students identify weaknesses and improve knowledge. We would like you to consider being an author or editor. Please click here to learn more. Thank you for you for your interest, the StatPearls Publishing Editorial Team.

Extramammary Paget Disease - Questions

Take a quiz of the questions on this article.

Take Quiz
A 67-year-old female complains of a pruritic rash on her genitals. An exam shows an erythematous, well-demarcated lesion that involves most of the labia majora. A biopsy reveals clusters of large, anaplastic cells infiltrating the epidermis with increased cytoplasm separating them from normal cells. The anaplastic cells stain for mucin. What is the most probable diagnosis?



Click Your Answer Below


Would you like to access teaching points and more information on this topic?

Improve Content - Become an Author or Editor and get free access to the entire database, free eBooks, as well as free CME/CE as it becomes available. If interested, please click on "Sign Up" to register.

Purchase- Want immediate access to questions, answers, and teaching points? They can be purchased above at Apps and eBooks.


Sign Up
A patient presents with eroded erythematous plaques in the perianal area. The patient has a history of colon adenocarcinoma. Which of following stains would be expected to be positive on histopathologic exam?



Click Your Answer Below


Would you like to access teaching points and more information on this topic?

Improve Content - Become an Author or Editor and get free access to the entire database, free eBooks, as well as free CME/CE as it becomes available. If interested, please click on "Sign Up" to register.

Purchase- Want immediate access to questions, answers, and teaching points? They can be purchased above at Apps and eBooks.


Sign Up
A 65-year-old female presents with the lesion seen in the picture. What is your next step in evaluation of this patient?

(Move Mouse on Image to Enlarge)
  • Image 238 Not availableImage 238 Not available
    Contributed by DermNetNZ
Attributed To: Contributed by DermNetNZ



Click Your Answer Below


Would you like to access teaching points and more information on this topic?

Improve Content - Become an Author or Editor and get free access to the entire database, free eBooks, as well as free CME/CE as it becomes available. If interested, please click on "Sign Up" to register.

Purchase- Want immediate access to questions, answers, and teaching points? They can be purchased above at Apps and eBooks.


Sign Up
What type of glands is most abundant in areas affected by Paget disease?



Click Your Answer Below


Would you like to access teaching points and more information on this topic?

Improve Content - Become an Author or Editor and get free access to the entire database, free eBooks, as well as free CME/CE as it becomes available. If interested, please click on "Sign Up" to register.

Purchase- Want immediate access to questions, answers, and teaching points? They can be purchased above at Apps and eBooks.


Sign Up
A 76-year-old man with no significant past medical history presents to the clinic with pruritis and burning involving his perineum for which he has been treated with over the counter zinc oxide and hydrocortisone from his primary care provider with no improvement. Exam reveals a 3.6 cm sharply demarcated plaque with numerous superficial erosions. A biopsy reveals clusters of large, anaplastic cells with abundant pale cytoplasm infiltrating the epidermis with some single cells scattered within the higher in the epidermis. Immunohistochemical staining confirms the diagnosis. Which of the following treatment options has the lowest rate of recurrence for treating this condition?



Click Your Answer Below


Would you like to access teaching points and more information on this topic?

Improve Content - Become an Author or Editor and get free access to the entire database, free eBooks, as well as free CME/CE as it becomes available. If interested, please click on "Sign Up" to register.

Purchase- Want immediate access to questions, answers, and teaching points? They can be purchased above at Apps and eBooks.


Sign Up

Extramammary Paget Disease - References

References

Yildiz P,Ronen S,Aung PP,Trinidad C,Kajoian A,Prieto VG, Extramammary Paget Disease-A Challenging Case. The American Journal of dermatopathology. 2018 Nov 8;     [PubMed]
Nakamura Y,Tanese K,Hirai I,Amagai M,Kawakami Y,Funakoshi T, Serum cytokeratin 19 fragment 21-1 and carcinoembryonic antigen combination assay as a biomarker of tumour progression and treatment response in extramammary Paget's disease. The British journal of dermatology. 2019 Feb 21;     [PubMed]
Molina GE,Khalifian S,Mull JL,Chen L,Rosman IS,Faulkner-Jones BE,Ngo KH,Demehri S,Cornelius LA,Wu PA, Topical Combination of Fluorouracil and Calcipotriene as a Palliative Therapy for Refractory Extramammary Paget Disease. JAMA dermatology. 2019 Feb 20;     [PubMed]
Jones MA,Edwards T,Ermolovich T, Brown macule on vulva of an elderly woman. JAAD case reports. 2019 Feb;     [PubMed]
Long V,Michelle LWT,Joyce LSS, A Unique and Rare Case of Extramammary Paget Disease With Concomitant Herpes Simplex. The American Journal of dermatopathology. 2019 Jan 29;     [PubMed]
Cervantes J,Rosen A,Cho JH, Enlarging Bump on the Scrotum. Skin appendage disorders. 2018 Nov;     [PubMed]
Valle L,Deig C,Wright R,High W, An advanced case of extramammary Paget disease: Safe and effective treatment in an inoperable elderly patient using extensive en face electron irradiation. JAAD case reports. 2019 Jan;     [PubMed]
Asel M,LeBoeuf NR, Extramammary Paget's Disease. Hematology/oncology clinics of North America. 2019 Feb;     [PubMed]
Yao H,Xie M,Fu S,Guo J,Peng Y,Cai Z,Jiang Y,Zheng D,Wang Z, Survival analysis of patients with invasive extramammary Paget disease: implications of anatomic sites. BMC cancer. 2018 Apr 10;     [PubMed]

Disclaimer

The intent of StatPearls is to provide practice questions and explanations to assist you in identifying and resolving knowledge deficits. These questions and explanations are not intended to be a source of the knowledge base of all of medicine, nor is it intended to be a board or certification review of Surgery-Urologic. The authors or editors do not warrant the information is complete or accurate. The reader is encouraged to verify each answer and explanation in several references. All drug indications and dosages should be verified before administration.

StatPearls offers the most comprehensive database of free multiple-choice questions with explanations and short review chapters ever developed. This system helps physicians, medical students, dentists, nurses, pharmacists, and allied health professionals identify education deficits and learn new concepts. StatPearls is not a board or certification review system for Surgery-Urologic, it is a learning system that you can use to help improve your knowledge base of medicine for life-long learning. StatPearls will help you identify your weaknesses so that when you are ready to study for a board or certification exam in Surgery-Urologic, you will already be prepared.

Our content is updated continuously through a multi-step peer review process that will help you be prepared and review for a thorough knowledge of Surgery-Urologic. When it is time for the Surgery-Urologic board and certification exam, you will already be ready. Besides online study quizzes, we also publish our peer-reviewed content in eBooks and mobile Apps. We also offer inexpensive CME/CE, so our content can be used to attain education credits while you study Surgery-Urologic.